NEWS

Oct 9

New Study: Patients Unlikely to See Out-Of-Pocket Drug Savings from IRA

Washington, DC – New research contradicts promises of savings at the pharmacy counter for Medicare beneficiaries from the Inflation...

Jun 10

New Data Reveals Strong Economic Impact of Texas Biopharmaceutical Industry

For Immediate Release June 5, 2024 Contact: Lisa Glass 512-695-3569 / lglass@rosscomm.com New Data Reveals Strong Economic Impact of...

Jan 18

New Study Reinforces That Expansion of IRA Price Setting Would Further Crush Patient Health, Innovative Treatments and U.S. Biopharma Jobs

The Latest Plan from Some House Democrats to Expand Government Drug Price Controls Will Lead to Further Declines in New Treatments for...

Aug 8, 2023

Dan Leonard Named Executive Director of We Work For Health

FOR IMMEDIATE RELEASE August 8, 2023 Washington, DC – At a time when preserving America’s leadership in life sciences innovation is...

Jul 7, 2023

CMS Final Guidance on Government-Mandated Drug Pricing Highlights Need for Renewed Focus on...

CMS Final Guidance on Government-Mandated Drug Pricing Highlights Need for Renewed Focus on Patients, Jobs and Cures Latest Announcement...

Jun 15, 2023

New Study Projects Devastating Losses to Drug Develop., Jobs & Patient Health in Biopharma Ecosystem

Washington, DC – A new study estimates that there would be 237 fewer FDA approvals of new medicines for patients battling cancer,...